Top Story


Norfolk Pension Fund has won a class action against a US pharmaceuticals company, in which it was found liable for securities fraud.

Represented by Robbins Geller Rudman and Dowd LLP, the jury’s verdict against the defendants, Puma Biotechnology Inc (Puma), was the culmination of around four years of litigation and a three-week trial throughout which Norfolk Pension Fund served as the lead plaintiff on behalf of all defrauded investors




Check out our latest news




Latest videos



Check out our latest appointments



Check out our latest features

Check out our latest jobs


An alternative approach
Laura Blows speaks to NEST’s CIO Mark Fawcett to discuss its investment into alternative asset classes

All change
Laura Blows speaks to PMI president Lesley Carline about how the institute is continuously adapting to cater to evolving industry requirements